BR0108958A - Orally administered controlled release system for daily administration of ciprofloxacin - Google Patents

Orally administered controlled release system for daily administration of ciprofloxacin

Info

Publication number
BR0108958A
BR0108958A BR0108958-7A BR0108958A BR0108958A BR 0108958 A BR0108958 A BR 0108958A BR 0108958 A BR0108958 A BR 0108958A BR 0108958 A BR0108958 A BR 0108958A
Authority
BR
Brazil
Prior art keywords
ciprofloxacin
controlled release
release system
orally administered
daily administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
BR0108958-7A
Other languages
Portuguese (pt)
Inventor
Naresh Talwar
Ashok Rampal
John N Staniforth
Gour Mukherji
Brij Khera
Badri N Vishwanathan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ranbaxy Laboratories Ltd
Original Assignee
Ranbaxy Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd
Publication of BR0108958A publication Critical patent/BR0108958A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Physiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"SISTEMA DE LIBERAçãO CONTROLADA, ADMINISTRADO ORALMENTE, PARA ADMINISTRAçãO DIáRIA DE CIPROFLOXACINA". Formulação oral na forma de comprimidos para a liberação controlada de ciprofloxacina, administrada uma vez ao dia em humanos, compreendendo uma quantidade farmaceuticamente eficaz de ciprofloxacina, cerca de 0,1% a cerca de 8,0% de um agente promotor de viscosidade e/ou agente formador de gel, cerca de 5% a cerca de 15% de um agente gerador de gás e cerca de 3% a cerca de 15% de um agente de expansão, ditos percentuais estando em peso/peso da composição."ORALLY CONTROLLED CONTROLLED RELEASE SYSTEM FOR DAILY CYPROFLOXACIN ADMINISTRATION". Oral once-daily controlled release tablet form of ciprofloxacin in humans comprising a pharmaceutically effective amount of ciprofloxacin, about 0.1% to about 8.0% of a viscosity promoting agent and / or gel forming agent, about 5% to about 15% of a gas generating agent and about 3% to about 15% of a blowing agent, said percentages being by weight / weight of the composition.

BR0108958-7A 2000-03-03 2001-02-28 Orally administered controlled release system for daily administration of ciprofloxacin Withdrawn BR0108958A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US51788700A 2000-03-03 2000-03-03
PCT/IB2001/000279 WO2001064183A1 (en) 2000-03-03 2001-02-28 Orally administered controlled delivery system for once daily administration of ciprofloxacin

Publications (1)

Publication Number Publication Date
BR0108958A true BR0108958A (en) 2003-09-30

Family

ID=24061635

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0108958-7A Withdrawn BR0108958A (en) 2000-03-03 2001-02-28 Orally administered controlled release system for daily administration of ciprofloxacin

Country Status (31)

Country Link
EP (1) EP1263409A1 (en)
JP (1) JP2003525229A (en)
KR (1) KR20030009374A (en)
CN (1) CN1420763A (en)
AP (2) AP1485A (en)
AR (1) AR032614A1 (en)
AU (1) AU3589701A (en)
BG (1) BG107055A (en)
BR (1) BR0108958A (en)
CA (1) CA2400950A1 (en)
CZ (1) CZ20022883A3 (en)
DO (1) DOP2001000130A (en)
EA (1) EA200200914A1 (en)
EC (1) ECSP013952A (en)
EE (1) EE200200497A (en)
GT (1) GT200100033A (en)
HN (1) HN2001000038A (en)
HR (1) HRP20020715A2 (en)
HU (1) HUP0204417A3 (en)
IL (1) IL151553A0 (en)
IS (1) IS6532A (en)
MX (1) MXPA02008568A (en)
NO (1) NO20024108L (en)
NZ (1) NZ520927A (en)
OA (1) OA12381A (en)
PE (1) PE20011113A1 (en)
PL (1) PL365071A1 (en)
SK (1) SK12542002A3 (en)
WO (1) WO2001064183A1 (en)
YU (1) YU66202A (en)
ZA (1) ZA200206764B (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0209265D0 (en) 2002-04-23 2002-06-05 Novartis Ag Organic compounds
US20030229101A1 (en) * 2002-06-06 2003-12-11 Sherman Bernard Charles Tablets comprising ciprofloxacin hydrochloride
DE10351448A1 (en) 2003-11-04 2005-06-09 Bayer Healthcare Ag Flavor-containing drug formulations with improved pharmaceutical properties
ATE396710T1 (en) * 2005-07-19 2008-06-15 Ethypharm Sa GASTRORETENTIVE COMPOSITIONS AND METHOD FOR PRODUCING
EP1880722B1 (en) * 2006-07-19 2010-03-17 Tabuk Pharmaceutical Manufacturing Co. Pharmaceutical compositions of ciprofloxacin
US10363288B2 (en) 2015-01-14 2019-07-30 National Jewish Health Insulin mimotopes and methods of using the same
CA3015400A1 (en) * 2016-02-23 2017-08-31 Matripharm International Inc. Dual-rate release formulation with high drug loading
AU2017236977B2 (en) 2016-03-24 2022-05-26 Immunomolecular Therapeutics, Inc. Methods of treating autoimmune disease
US11052060B2 (en) 2018-02-12 2021-07-06 The Regents Of The University Of Colorado, A Body Corporate Compounds and methods for treating autoimmunity
US11013707B2 (en) 2018-03-23 2021-05-25 The Regents Of The University Of Colorado, A Body Corporate Administration of oral methyldopa
CN109806237A (en) * 2019-03-13 2019-05-28 悦康药业集团上海制药有限公司 A kind of Ciprofloxacin Lactate effervescent tablet and preparation method thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5096714A (en) * 1988-06-28 1992-03-17 Hauser-Kuhrts, Inc. Prolonged release drug tablet formulations
JPH0624959A (en) * 1991-10-04 1994-02-01 Bayer Yakuhin Kk Medice release solid pharmaceutical preparation of gastric suspending type sustained
DE4406424A1 (en) * 1994-02-28 1995-08-31 Bayer Ag Expandable dosage forms
DE19839057A1 (en) * 1998-08-28 2000-03-02 Koch Berthold Purge air controller for a drying device for compressed air
EE200100153A (en) * 1998-09-14 2002-06-17 Ranbaxy Laboratories Limited Controlled drug delivery system for oral drug delivery that provides temporal and spatial control

Also Published As

Publication number Publication date
CZ20022883A3 (en) 2003-04-16
EA200200914A1 (en) 2003-02-27
IS6532A (en) 2002-08-28
HRP20020715A2 (en) 2004-12-31
OA12381A (en) 2004-09-06
MXPA02008568A (en) 2003-02-24
DOP2001000130A (en) 2004-03-31
CA2400950A1 (en) 2001-09-07
AP2001002084A0 (en) 2001-03-31
EP1263409A1 (en) 2002-12-11
AP2002002627A0 (en) 2002-09-30
KR20030009374A (en) 2003-01-29
IL151553A0 (en) 2003-04-10
PL365071A1 (en) 2004-12-27
AP1485A (en) 2005-10-31
AU3589701A (en) 2001-09-12
GT200100033A (en) 2001-10-25
HUP0204417A2 (en) 2003-05-28
BG107055A (en) 2003-06-30
AR032614A1 (en) 2003-11-19
ZA200206764B (en) 2003-03-04
ECSP013952A (en) 2002-04-23
NZ520927A (en) 2003-06-30
HUP0204417A3 (en) 2005-03-29
SK12542002A3 (en) 2003-05-02
YU66202A (en) 2005-09-19
PE20011113A1 (en) 2001-10-14
EE200200497A (en) 2004-02-16
NO20024108L (en) 2002-10-25
NO20024108D0 (en) 2002-08-28
WO2001064183A1 (en) 2001-09-07
HN2001000038A (en) 2005-03-23
JP2003525229A (en) 2003-08-26
CN1420763A (en) 2003-05-28

Similar Documents

Publication Publication Date Title
BR0109875A (en) Treatment of respiratory diseases
CO5190672A1 (en) COMPOSITION FOR ORAL DOSAGE, INSTANT DISSOLUTION
BRPI0518266B8 (en) oral drug with modified release of at least one active ingredient in multimicrocapsular form
BRPI0414907A (en) injectable, oral or topical sustained release pharmaceutical formulations
ATE215816T1 (en) SOLID ORAL MEDICINAL FORM
RS50303B (en) Controlled release pharmaceutical composition comprising nimesulide
BR9916224A (en) Oral pharmaceutical dosage form, processes for the manufacture of a fixed dosage form, for the treatment and prophylaxis of gastrointestinal disorders and to prevent gastrointestinal side effects, use of a dosage form, combination, and ampoule packaging
BRPI0408999A (en) compressed prolonged oral release multiparticulate tablets
BR0108958A (en) Orally administered controlled release system for daily administration of ciprofloxacin
BR9901782A (en) Nefazodone dosage form.
BR0209283A (en) Method for the manufacture of a low dosage pharmaceutical composition having uniform drug distribution and potency
BR0013719A (en) Controlled-release oral dosage, suitable for oral administration
IS7006A (en) Dihydrogen 3-piperidinopropiophenone and medicinal products containing said compounds
ES2171440T3 (en) SOLID COMPOSITION MUCOADHESIVA, THERAPEUTICS OR HYGIENIC, FOR ADMINISTRATION BY APPLICATION ON THE MUCOSA ORAL OR NASAL.
AR046036A1 (en) RISEDRONATE COMPOSITIONS AND METHODS FOR USE
PT1425005E (en) PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS LUMIRACOXIB
BRPI0412430A (en) zot and zonulin receptor agonist polypeptide
BR0207866A (en) Use of flumazenil in the preparation of a drug for the treatment of cocaine addiction
BR0014440A (en) Oral controlled release formulations
HRP20020258B1 (en) Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive
HUP0201629A2 (en) Pharmaceutical complex containing eletriptan and cyclodextrin-derivative, pharmaceutical composition containing it, process for its preparation and its use
BR0210063A (en) Stable composition and use
BR0012822A (en) Pharmaceutical Formulation and Tablet Dosage Form
DE60007074D1 (en) SULFATED PHOSPHATIDYLINOSITOLS, THEIR PRODUCTION AND USE
DK0927031T3 (en) Pharmaceutical composition containing nimesulide for oral administration

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE 7A. E 8A. ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 2008 DE 30/06/2009.